Opko Health Loss Widens

(RTTNews) - Biopharmaceuticals company Opko Health Inc (OPK) Friday reported first-quarter net loss of $44.6 million or $0.11 per share compared with a loss of $34.6 million last year.

Results were partly due to the prior year's $12.5 million of non-cash income related to the RXi transaction.

Revenues for the quarter were lower at $22.3 million compared with $31.3 million in the prior year.

Analysts polled by Thomson Reuters estimated a loss of $0.10 per share on revenues of $22.77 million for the quarter. Analysts' estimates typically exclude special items.

Total expenses for the quarter grew to $52.6 million from $38 million a year ago, partly reflecting higher research expense.